Iranian nanotechnology offers new approach to bone regeneration

An Iranian biotechnology company has unveiled a new nanoengineered synthetic bone graft designed to accelerate safe and effective bone regeneration in spinal, orthopedic and dental surgeries.

The innovation was presented by Tavakkol Biomimetic Technologies at the Iran Advanced Technologies Exhibition.

According to Iran’s Vice-Presidency for Science, the company has introduced a swelling nano-bone powder branded as Nemimetik, a biomimetic graft inspired by the natural structure of bone.
The material aims to eliminate risks associated with human and animal grafts, including infection, immune reactions and inflammation.

The product is manufactured in several forms, including powder, granules, soft and hard cubes, and soft and hard matchsticks, allowing surgeons to select the most suitable option for specific procedures.

Clinical tests cited by authorities indicate that the graft can boost bone regeneration by up to 75 percent in granule form and 63 percent in powder form, positioning nanotechnology as a competitive alternative to imported products.

Currently, more than 82 percent of Iran’s synthetic bone graft market relies on imports, while about 26,000 surgeries each year require such materials.
Local production of Nemimetik could significantly reduce dependence on foreign suppliers, improve hospital access to advanced grafts and save foreign currency.